Market outlook of the global bone and mineral diagnostic testing market
Osteoporosis, Paget's disease, and osteogenesis imperfecta are examples of common bone diseases that are caused due to the acute shortage of minerals like calcium, phosphorus, and vitamin D. Technavio’s market research analyst has estimated factors like the growing awareness of diagnostic testing among the populace, rapid advances in technology, and increased number of product launches and approvals from regulatory authorities to result in this market’s steady growth rate of more than 4.3% by 2019.
Geographically, the Americas are expected to account for more than 50% of the total market share by 2019. High market dominion of this region can be attributed to the prevalence of diseases such as Paget's disease and osteoporosis in the US. Also, the recent rise in laboratory automation and increased FDA approval for new products also boost the prospects for growth in this market during the forecast period.
Application-based segmentation of the bone and mineral diagnostic testing market
- Vitamin D testing
- Bone metabolism
In this market research report, analysts estimate the vitamin D testing segment to account for more than 77% of the total market share by 2019. Its ability to determine bone weaknesses, bone malformation, or abnormal metabolism of calcium is expected to account for its high market share during the forecast period.
Segmentation by product and analysis of the bone and mineral diagnostic testing market
- Instruments
- Assays/consumables
The assays/consumables segment is expected to account for a market share of close to 85% during the period of 2014 and 2019. Their usefulness in detecting the presence and type of elements such as hormones, vitamins, and specific proteins in a patient’s blood sample results in its high market share during the forecast period. Additionally, their ability to generate high ROI for manufacturers is expected to result in this segment’s growth in the next four years.
Competitive landscape and key vendors
This market is highly fragmented due to the presence of multiple medium- and small-sized manufacturers who provide immunodiagnostic test kits for bone and mineral metabolism. The large companies in this market face intense competition from the smaller vendors as they provide cost-effective products to the patients. Vendors in this market compete on the basis of price, quality, range of products, and distribution capabilities to gain prominence in this market during the forecast period.
Leading vendors in this market are -
- Abbott Diagnostics
- bioMérieux
- Diasorin
- Roche Diagnostic
- Siemens Healthcare
- Quidel
Other prominent vendors analyzed in this market study are Alere, ALPCO, Beckman Coulter, Biomedica Immunoassays, Bio-Rad Laboratories, Calbiotech, DIAsource ImmunoAssays, DRG INSTRUMENTS, Eagle BioSciences, Enzo Life Sciences, Epitope Diagnostics, IBL International, Immundiagnostik, Immunodiagnostic Systems, IASON, ORGENTEC Diagnostika, Orion Diagnostica, Ortho-Clinical Diagnostics, and TECOmedical.
Key questions answered in the report include
- What will the market size and the growth rate be in 2019?
- What are the key factors driving the global bone and mineral diagnostic testing market?
- What are the key market trends impacting the growth of the global bone and mineral diagnostic testing market?
- What are the challenges to market growth?
- Who are the key vendors in the global bone and mineral diagnostic testing market?
- What are the market opportunities and threats faced by the vendors in the global bone and mineral diagnostic testing market?
- Trending factors influencing the market shares of the EMEA, Americas, and APAC?
- What are the key outcomes of the five forces analysis of the global bone and mineral diagnostic testing market?
Technavio also offers customization on reports based on specific client requirement.
Related reports
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Reimbursement and coverage: An overview
- Current scenario: Validating diagnostic tests
- Reimbursement structure in the US
- Reimbursement structure in EU
- Prevailing issues of reimbursement policies
PART 07: Market segmentation by application
- Vitamin D testing
- Bone metabolism
PART 08: Market segmentation by technology
PART 09: Market segmentation by product
- Assays/consumables
- Instruments
PART 10: Geographical segmentation
- Bone and mineral diagnostic testing market in Americas
- Bone and mineral diagnostic testing market in EMEA
- Bone and mineral diagnostic testing market in APAC
PART 11: Market drivers
- Increasing incidence of bone disorders
- Early diagnosis and preventive medicine
- Increase in geriatric population
PART 12: Impact of drivers
PART 13: Market challenges
- Pricing erosion in established countries
- Limited detection capability and complexity
- Reimbursement and regulatory hurdles
PART 14: Impact of drivers and challenges
PART 15: Market trends
- Development in automation of assays
- Growing focus on emerging countries
- Focus on POC diagnostic tests
- Increase in awareness and role of government and non-profit institutions
PART 16: Vendor landscape
- Competitive scenario
- Key vendor analysis 2014
- Other prominent vendors
PART 17: Key vendor analysis
- Abbott Diagnostics
- bioMérieux
- DiaSorin
- Roche Diagnostics
- Siemens Healthcare
- Quidel
PART 18: Appendix
PART 19: Explore Technavio